These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
98 related items for PubMed ID: 11202638
1. [Present-day aspects (diagnosis, clinical course and treatment) of acute progressive pulmonary tuberculosis]. Mishin VIu. Vestn Ross Akad Med Nauk; 2000; (12):21-5. PubMed ID: 11202638 [Abstract] [Full Text] [Related]
2. [Diagnosis, clinical picture and treatment policy in acute progressive forms of pulmonary tuberculosis under present-day epidemiological conditions]. Khomenko AG, Mishin VIu, Chukanov VI, Korneev AA, Voronina GA, Vasil'eva IA. Probl Tuberk; 1999; (1):22-7. PubMed ID: 10199178 [Abstract] [Full Text] [Related]
3. API TB Consensus Guidelines 2006: Management of pulmonary tuberculosis, extra-pulmonary tuberculosis and tuberculosis in special situations. API Consensus Expert Committee. J Assoc Physicians India; 2006 Mar; 54():219-34. PubMed ID: 16800350 [Abstract] [Full Text] [Related]
4. [Diagnosis and treatment of acute progressive tuberculosis types]. Khomenko AG, Mishin VI. Probl Tuberk; 1996 Mar; (5):21-3. PubMed ID: 8984482 [Abstract] [Full Text] [Related]
5. Short-course chemotherapy in pulmonary tuberculosis. A controlled trial by the British Thoracic and Tuberculosis Association. Lancet; 1975 Jan 18; 1(7899):119-24. PubMed ID: 46047 [Abstract] [Full Text] [Related]
6. [Surgical treatment of patients with multi-resistant pulmonary tuberculosis--case reports]. Michałowska-Mitczuk D, Kuś J. Pneumonol Alergol Pol; 1997 Jan 18; 65(3-4):249-53. PubMed ID: 9489423 [Abstract] [Full Text] [Related]
7. [Clinical efficiency of combined chemotherapy of patients with progressive forms of pulmonary tuberculosis]. Cheren'ko SO. Lik Sprava; 2001 Jan 18; (1):76-80. PubMed ID: 15311700 [Abstract] [Full Text] [Related]
9. Early bactericidal activity of ethambutol, pyrazinamide and the fixed combination of isoniazid, rifampicin and pyrazinamide (Rifater) in patients with pulmonary tuberculosis. Botha FJ, Sirgel FA, Parkin DP, van de Wal BW, Donald PR, Mitchison DA. S Afr Med J; 1996 Feb 18; 86(2):155-8. PubMed ID: 8619142 [Abstract] [Full Text] [Related]
11. [Case of pulmonary multi-drug resistant tuberculosis with left destroyed lung, treated with pneumonectomy]. Koyama K, Kawakami K, Harada Y, Yamaryo T, Kimura Y. Kekkaku; 2007 Jul 18; 82(7):577-81. PubMed ID: 17695788 [Abstract] [Full Text] [Related]
12. [Effectiveness of the standard mode of chemotherapy for newly-diagnosed patients with destructive pulmonary tuberculosis with bacterial isolation]. Mishin VIu, Chukanov VI, Vylegzhanin SV. Probl Tuberk; 2001 Jul 18; (7):13-8. PubMed ID: 11763553 [Abstract] [Full Text] [Related]
13. Factors influencing time to smear conversion in patients with smear-positive pulmonary tuberculosis. Wang JY, Lee LN, Yu CJ, Chien YJ, Yang PC, Tami Group. Respirology; 2009 Sep 18; 14(7):1012-9. PubMed ID: 19659516 [Abstract] [Full Text] [Related]
14. A controlled clinical trial of oral short-course regimens in the treatment of sputum-positive pulmonary tuberculosis. Tuberculosis Research Centre. Int J Tuberc Lung Dis; 1997 Dec 18; 1(6):509-17. PubMed ID: 9487448 [Abstract] [Full Text] [Related]
15. [Etiopathogenesis, clinical picture and treatment of progressive forms of pulmonary tuberculosis]. Suslov VA. Voen Med Zh; 1996 Jul 18; 317(7):29-34, 80. PubMed ID: 8967037 [No Abstract] [Full Text] [Related]
16. [Fully supervised ambulatory short-course chemotherapy with an intermittent regimen for newly diagnosed smear-positive pulmonary tuberculosis]. Xu RX. Zhonghua Jie He He Hu Xi Za Zhi; 1987 Oct 18; 10(5):261-3, 307. PubMed ID: 3131029 [No Abstract] [Full Text] [Related]
17. [Efficiency of a new standard chemotherapy regimen in the treatment of patients with recurrent pulmonary tuberculosis]. Chukanov VI, Komissarova OG, Maishin VIu, Abdullaev RIu, Kononets AS. Probl Tuberk Bolezn Legk; 2006 Oct 18; (8):9-13. PubMed ID: 17002050 [Abstract] [Full Text] [Related]
18. [The course of a process and the efficiency of treatment of pulmonary tuberculosis patients excreting Mycobacterium tuberculosis with extensive drug resistance to antituberculous drugs]. Mishin VIu, Komissarova OG, Chukanov VI, Kononets AS. Probl Tuberk Bolezn Legk; 2009 Oct 18; (2):50-2. PubMed ID: 19382643 [Abstract] [Full Text] [Related]
19. Treatment of isoniazid-resistant tuberculosis with isoniazid, rifampin, ethambutol, and pyrazinamide for 6 months. Nolan CM, Goldberg SV. Int J Tuberc Lung Dis; 2002 Nov 18; 6(11):952-8. PubMed ID: 12475140 [Abstract] [Full Text] [Related]
20. Drug resistance to the first line of antitubercular regimen (a preliminary report). Varaiya A, Gogate A. Indian J Public Health; 1998 Nov 18; 42(4):126-30. PubMed ID: 10389525 [Abstract] [Full Text] [Related] Page: [Next] [New Search]